Taken together, the results obtained in this study show that either loss or constitutive activation of Nrf2 in an AD-like mouse model aggravates the phenotype by interference with normal keratinocyte differentiation and, most likely, by increasing barrier dysfunction and cell damage. This evidence concerns the gene NFE2L2 and Alzheimer disease.